Bright Path Pharmaceuticals

Mr. Allen is the former CEO of Vault Pharma, an immunology biotechnology company.  He has extensive experience in the life sciences and financial services sectors.  He was the former Chief Business Officer of Sun BioPharma (OTCQB:SNBP) which achieved it first-in-human for pancreatic cancer in the summer of 2015.  He has served as a consultant to Horizon Pharma (NASDAQ: HNZP); Jemsek Specialty Clinic, a leading provider of Lyme’s Disease treatment; OptionsXpress (NASDAQ: OXPS) acquired by Schwab; Paragon28, LLC, a Foot & Ankle medical device company; Elliott Davis, the largest CPA firm in the Southeast; Horizon Investments, a leading independent asset management firm; and United Capital Partners, a $20B wealth management firm.  Mr. Allen was held numerous positions in the pharmaceutical industry with Pfizer, Agouron and The Upjohn Company and holds a B.S. in Chemistry from Wofford College.  He is a member of the American Chemical Society.

Mr. Allen serves on the Boards of three non-profit groups including: The FIRE Leadership Foundation (; StarZ24 ( and Gateway Partners International (